ZBD(SH:603567) Shang Hai Zheng Quan Bao·2025-06-16 20:40Group 1 - The company plans to provide a guarantee of up to RMB 200 million for its associate company, Anhui Jiuzhou Fangyuan Pharmaceutical Co., Ltd. [2][6] - As of the announcement date, the company has not provided any guarantees for Anhui Jiuzhou Fangyuan, with a total external guarantee amount of RMB 1.591 billion, all for wholly-owned subsidiaries [3][16] - The guarantee will be for a term of 12 months and is intended to support the bank financing needs of Anhui Jiuzhou Fangyuan [6][14] Group 2 - The board of directors approved the guarantee proposal during a meeting held on June 15, 2025, and it will require shareholder approval [7][8] - The company holds a 34.8182% stake in Anhui Jiuzhou Fangyuan, which has a debt-to-asset ratio exceeding 70% [10][5] - The company has no overdue guarantees and considers the guarantee risk to be controllable, with Anhui Jiuzhou Fangyuan having sufficient debt repayment capability [15][16] Group 3 - A temporary proposal to include the guarantee in the upcoming annual shareholder meeting was submitted by the controlling shareholder, Heilongjiang Chuangda Group Co., Ltd. [20][21] - The annual shareholder meeting is scheduled for June 25, 2025, and will include the discussion of the guarantee proposal [20][21] - The company will utilize the Shanghai Stock Exchange's online voting system for shareholder participation during the meeting [21]